David S. Kozin Posted May 28, 2010 Report Posted May 28, 2010 NEW ORLEANS -- The atypical antipsychotic aripiprazole (Abilify) appears to be safe for longer-term treatment of irritability associated with autism, but patients are at an increased risk of weight gain, researchers said here. View the full article
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now